1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with bm 13505 in 9 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (bm 13505) | Trials (bm 13505) | Recent Studies (post-2010) (bm 13505) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 124 | 0 | 13 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | bm 13505 (IC50) |
|---|---|---|---|
| Thromboxane A2 receptor | Homo sapiens (human) | 0.305 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babycos, CR; Hood, JS; Ibrahim, IN; Kadowitz, PJ; McMahon, TJ; Nossaman, BD | 1 |
| Feuerstein, G; Lynch, KM; Ohlstein, EH; Poyser, R; Rabinovici, R; Sellers, TS; Slivjak, MJ; Smith, EF; Sulpizio, A; Yue, TL | 1 |
| Dyson, MC; Kadowitz, PJ | 1 |
| Neugarten, J; Schlondorff, D; Yoo, J | 1 |
| Ernst, A; Mest, HJ; Riedel, A; Syka, J | 1 |
| Fletcher, JR; Khimenko, PL; Logsdon, P; Rizzo, A; Taylor, AE; Townsley, MI | 1 |
| Bretschneider, E; Glusa, E; Schrör, K | 1 |
| Gulbins, E; Rauterberg, EW; Schlottmann, K; Steinhausen, M | 1 |
| Gresele, P; Mezzasoma, AM; Venditti, G; Vezza, R | 1 |
9 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bm 13505
| Article | Year |
|---|---|
Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Blood Pressure; Cats; Endothelins; Female; Male; Phenylacetates; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin; Sulfonamides; Thromboxane A2; Vasoconstrictor Agents | 1992 |
Pharmacological profile of G619, a new platelet aggregation inhibitor.
Topics: Adenosine Diphosphate; Animals; Benzamides; Calcium; Collagen; Dogs; Epinephrine; Fibrinogen; Humans; Male; Phenylacetates; Picolines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Shock, Septic; Sulfonamides; Thrombin; Thromboxane B2; Vasoconstriction | 1992 |
Influence of SK&F 96148 on thromboxane-mediated responses in the airways of the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Resistance; Animals; Arachidonic Acid; Arachidonic Acids; Cats; Endothelins; Endotoxins; Escherichia coli; Female; Male; Phenylacetates; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Respiratory Physiological Phenomena; Respiratory System; Sulfonamides; Thromboxane A2; Thromboxanes | 1991 |
Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
Topics: Animals; Blood Pressure; Drug Interactions; Glomerular Filtration Rate; Hematocrit; Indomethacin; Kidney; Male; Phenylacetates; Platelet Activating Factor; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Renal Circulation; Sulfonamides; Thromboxane B2 | 1990 |
The effect of PAF in the cochlea of guinea pigs.
Topics: Acoustic Stimulation; Animals; Blood Pressure; Cochlea; Diterpenes; Electrophysiology; Evoked Potentials, Auditory; Female; Ginkgolides; Guinea Pigs; Lactones; Male; Phenylacetates; Platelet Activating Factor; Sulfonamides | 1989 |
Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
Topics: Animals; Azepines; Blood Pressure; Capillary Permeability; Hindlimb; Ibuprofen; Male; Phenylacetates; Platelet Activating Factor; Rats; Rats, Wistar; Regional Blood Flow; Sulfonamides; Thromboxane A2; Thromboxanes; Triazoles; Vascular Resistance | 1995 |
ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Calcium; Citric Acid; Collagen; Epinephrine; Glucose; Hirudins; Humans; Indomethacin; Phenylacetates; Platelet Activating Factor; Platelet Aggregation; Receptors, Thromboxane; Recombinant Proteins; Sulfonamides; Thromboxanes | 1994 |
Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys.
Topics: Animals; Antibodies; Complement C5a; Female; Glomerular Filtration Rate; Hydronephrosis; Indazoles; Neutrophils; Phenylacetates; Platelet Activating Factor; Rats; Rats, Wistar; Recombinant Proteins; Reference Values; Renal Circulation; SRS-A; Sulfonamides; Thromboxanes; Vasoconstriction | 1993 |
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Unsaturated; Heptanoic Acids; Humans; Hydrazines; Imidazoles; Inositol Phosphates; Kidney; Methacrylates; Phenylacetates; Platelet Activating Factor; Platelet Activation; Prostaglandin H2; Prostaglandins H; Protein Isoforms; Receptors, Thromboxane; Recombinant Fusion Proteins; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 2002 |